Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2006. Start Trial.
Date Value
September 30, 2026 67.30%
August 31, 2026 67.30%
July 31, 2026 67.30%
June 30, 2026 67.30%
May 31, 2026 67.30%
April 30, 2026 67.30%
March 31, 2026 67.30%
February 28, 2026 67.30%
January 31, 2026 67.30%
December 31, 2025 71.62%
November 30, 2025 72.49%
October 31, 2025 76.90%
September 30, 2025 76.90%
August 31, 2025 76.90%
July 31, 2025 76.90%
June 30, 2025 76.90%
May 31, 2025 76.90%
April 30, 2025 77.78%
March 31, 2025 78.25%
February 28, 2025 80.91%
January 31, 2025 80.91%
December 31, 2024 80.91%
November 30, 2024 80.91%
October 31, 2024 84.04%
September 30, 2024 84.04%
Date Value
August 31, 2024 85.00%
July 31, 2024 85.00%
June 30, 2024 85.00%
May 31, 2024 85.00%
April 30, 2024 85.00%
March 31, 2024 85.00%
February 29, 2024 85.00%
January 31, 2024 85.00%
December 31, 2023 85.00%
November 30, 2023 85.00%
October 31, 2023 85.00%
September 30, 2023 85.00%
August 31, 2023 85.00%
July 31, 2023 85.00%
June 30, 2023 85.00%
May 31, 2023 85.00%
April 30, 2023 85.00%
March 31, 2023 85.00%
February 28, 2023 85.00%
January 31, 2023 85.00%
December 31, 2022 85.00%
November 30, 2022 85.00%
October 31, 2022 85.00%
September 30, 2022 85.00%
August 31, 2022 85.00%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
AstraZeneca PLC 27.87%
ANI Pharmaceuticals, Inc. 72.96%
Corcept Therapeutics, Inc. 71.85%
Veru, Inc. 99.12%
Avadel Pharmaceuticals Plc 90.89%